Literature DB >> 8739257

Helicobacter pylori infection and its role in human disease--an overview.

K E McColl1.   

Abstract

Helicobacter pylori (H. pylori) is probably the commonest chronic bacterial infection in humans. The bacterium colonizes the gastric epithelium and induces inflammation of the underlying mucosa. The recognition that this infection is the most important acquired factor in the pathogenesis of duodenal and gastric ulcers has transformed the management of these common disorders. Most patients with ulcers can be cured by a 1-week course of anti-H. pylori therapy, thereby removing the need for long-term acid inhibitory therapy. Eradication of the infection involves taking complex combinations of drugs and simpler eradication regimens are required. Recent epidemiological data indicate an association between H. pylori infection and the subsequent development of gastric carcinoma. If this association is established as causal, then widespread eradication of the infection may be indicated. Global eradication of H. pylori will probably rely on prophylactic or therapeutic vaccination and this approach is being actively investigated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739257     DOI: 10.1007/bf00579705

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  77 in total

1.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

2.  Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma.

Authors:  L E Hansson; L Engstrand; O Nyrén; D J Evans; A Lindgren; R Bergström; B Andersson; L Athlin; O Bendtsen; P Tracz
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

3.  Rapid urease test in the management of Campylobacter pyloridis-associated gastritis.

Authors:  B J Marshall; J R Warren; G J Francis; S R Langton; C S Goodwin; E D Blincow
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

4.  Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.

Authors:  M T al-Assi; F C Ramirez; G M Lew; R M Genta; D Y Graham
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

5.  Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach.

Authors:  H Kaneko; K Nakada; T Mitsuma; K Uchida; A Furusawa; Y Maeda; K Morise
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

6.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.

Authors:  E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

7.  Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.

Authors:  E M el-Omar; I D Penman; J E Ardill; R S Chittajallu; C Howie; K E McColl
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

8.  Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.

Authors:  S W Hosking; T K Ling; S C Chung; M Y Yung; A F Cheng; J J Sung; A K Li
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

9.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

10.  Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach.

Authors:  G M Sobala; B Pignatelli; C J Schorah; H Bartsch; M Sanderson; M F Dixon; S Shires; R F King; A T Axon
Journal:  Carcinogenesis       Date:  1991-02       Impact factor: 4.944

View more
  3 in total

1.  Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects.

Authors:  A Mattsson; M Quiding-Järbrink; H Lönroth; A Hamlet; I Ahlstedt; A Svennerholm
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Evidence for specific secretion rather than autolysis in the release of some Helicobacter pylori proteins.

Authors:  A Vanet; A Labigne
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  Helicobacter pylori expresses an autolytic enzyme: gene identification, cloning, and theoretical protein structure.

Authors:  Eleonora Marsich; Pierfrancesco Zuccato; Sonia Rizzi; Amedeo Vetere; Enrico Tonin; Sergio Paoletti
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.